Personalised medicine

#Immuno-oncology #Immunotherapy #Oncology #Personalised medicine

Navigating the landscape of immunotherapy

Giusy Di Conza, Head of Research at iOnctura, explores the challenges of current immunotherapy approaches for cancer and where opportunity lies. Immunotherapy has transformed modern oncology. Immune checkpoint inhibitors like pembrolizumab and nivolumab revolutionised melanoma treatment by enhancing immune responses; ensuring it could become a manageable disease – with improved… Read More

#Cancer Research #Exclusive Content

Myeloma cells
#Genetics #Myeloma #Oncology #Personalised medicine #The Institute of Cancer Research

Personalised treatment needed for high-risk myeloma, say scientists

Offering genetic testing to patients with myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, say scientists.  With effective treatment, more than half of myeloma patients will survive their disease for five years… Read More

#Cancer Research #Editor's Choice #News

Human cells
#Drug delivery #Genomics #Oncology #Personalised medicine #Spatial biology

The opportunity for spatial biology in drug discovery  

DDW Editor Reece Armstrong speaks to Ellie Mahjubi, Vice President, Protein and cell analysis at Thermo Fisher Scientific, about how spatial biology is impacting drug discovery and development research.   RA: What’s the future and potential for spatial biology?  EM: Technological advancements in spatial… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automated workflows #Automation #Automation / robotics #Biopharma #Biopharmaceuticals #Data science #Drug development #Drug discovery #Lab automation #Lab technology #Personalised medicine #Pharmaceuticals

New podcast: How technology is impacting drug discovery

This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and… Read More

#News

Genomics
#Clinical trials #Genetics / genomics #Interview #Personalised medicine #Rare disease

Sitting down with… Dr Patrick Short, Sano Genetics

DDW’s Diana Spencer caught up with Dr Patrick Short, CEO and Co-Founder, Sano Genetics, about the challenges facing personalised medicine development and his own personal experience of genetic conditions. DS: You and your co-founders met at the University of Cambridge. Can you tell us about the founding of the company?… Read More

#Exclusive Content

Simon and Vanessa Conn
#Cancer treatment #circular RNAs #Flinders University #Oncology #Personalised medicine #RNA

Harnessing circRNAs could “change the landscape” of cancer therapy

Circular RNAs (circRNAs) have “remarkable potential” to improve cancer treatment and patient outcomes within the next five to 10 years, according to a new study by Flinders University in Australia. The research was led by Senior Researcher Dr Vanessa Conn and Professor Simon Conn, who leads… Read More

#Cancer Research #Editor's Choice #News

Vaccine production
#Cancer vaccine #mRNA #mRNA-based vaccines #Oncology #Personalised medicine #University of Queensland

Personalised cancer vaccines to be produced at Queensland lab

A new facility at The University of Queensland, Australia, will provide researchers with cancer vaccines tailored to individual patients. The lab at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) will bring together the equipment and expertise to enable the design, manufacture and delivery of new… Read More

#News

#Cell Science #Enhanc3D Genomics #Genetics / genomics #Personalised medicine

How 3D genomics can accelerate personalised medicine

Dr Daniel Turner, Chief Scientific Officer, Enhanc3D Genomics, outlines how 3D genomics offers a radically novel approach to address challenges in drug target discovery and how it can affect change in drug target identification, cell therapy and personalised medicine.  3D genome folding DNA within the cell nucleus is more… Read More

#Exclusive Content

#Cancer research #Cancer vaccine #CAR-T #Clinical trial #Oncology #Personalised medicine

New DDW Highlights podcast: 29 April 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The leading news story this week has been the launch of a new clinical… Read More

#News

#Cancer research #Cancer vaccine #CAR-T #Clinical trial #Oncology #Personalised medicine

This week in drug discovery (22-26 April) 

News round-up for 22-26 April by DDW Digital Content Editor Diana Spencer. The leading news story this week has been the launch of a new clinical trial in the UK for a melanoma personalised mRNA cancer vaccine, but there have been a number of other interesting developments in… Read More

#News

Genomics
#AI / data analytics / healthtech / informatics #Events #Genetics / genomics #Lifebit #Personalised medicine

What are the trends in genomics and precision medicine for 2024?

Leading experts in genomics, personalised medicine and drug discovery convened at the Precision Medicine Community Event in London to unveil the latest advancements shaping the future of healthcare. The event highlighted critical areas such as secure and diverse data access, genomic sequencing in newborns, building public… Read More

#News

Scientific technology
#AI / data analytics / healthtech / informatics #Clinical development #Data automation #Data management #Diagnostics #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Genomics #Immunology / Virology & Vaccines #Infectious diseases #Informatics #mRNA #Personalised medicine #Precision medicine #Predictive diagnostics #Public health

New podcast: Revolutionary technology for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More

#News

AI genomics concept
#AI / data analytics / healthtech / informatics #Biobanking #Genomics #Personalised medicine

Supercharging AI-drug discovery with strategic multiomic biobanks 

Niven R. Narain, PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market.   Artificial Intelligence (AI) has become a popular buzzword in the drug discovery and development lexicon but not all… Read More

#Exclusive Content

Hospital patient on ventilator
#Biomarkers #Collaboration #Covid-19 #GeNeuro #Long Covid #Personalised medicine #Verily

Partners take a personalised approach to long Covid

GeNeuro and Verily will work together to investigate biomarkers related to activation of the proinflammatory HERV-W envelope protein (W-ENV) in SARS-CoV-2 infection. Through this collaboration, the companies will build on results published earlier this year, which evidenced the in vitro activation of HERV-W by SARS-CoV-2 in… Read More

#Editor's Choice #News

#Drug discovery #Interview #Next generation sequencing #NGS #Personalised medicine

The use-case for NGS

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Dr Darrell Green, Lecturer in RNA Biology, Biomedical Research Centre, Norwich Medical School University of East Anglia, about his work using next generation sequencing (NGS) and the areas the technology is… Read More

#Exclusive Content

Cancer cell
#Biomarkers #Breast cancer #Cancer research #Genetics / genomics #Oncology #Personalised medicine #The Institute of Cancer Research

Genetic biomarkers could personalise therapy for TNBC

A new study has shed light on the genetic messages encoded by genes within ‘triple negative’ breast cancers (TNBC), and shows they could predict response to chemotherapy. The study, by researchers at The Institute of Cancer Research, London, shows that certain characteristics within patients’ primary tumours… Read More

#Cancer Research #News #Trending News